Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

<ul>
<li>Nomad Foods' second quarter 2024 earnings showcased a mix of strengths and cautious optimism amidst a slowly improving European market.</li>
<li>CEO Stefan Descheemaeker affirmed a positive shift with the company reporting its first period of volume growth (1.6%) since the third quarter of 2021.</li>
<li>This growth contributed to a 1.1% increase in net sales, reaching EUR 753 million, which was partly supported by a favorable foreign exchange impact of 0.6%.</li>
</ul>


Nomad Foods' second quarter 2024 earnings showcased a mix of strengths and cautious optimism amidst a slowly improving European market.
CEO Stefan Descheemaeker affirmed a positive shift with the company reporting its first period of volume growth (1.6%) since the third quarter of 2021.
This growth contributed to a 1.1% increase in net sales, reaching EUR 753 million, which was partly supported by a favorable foreign exchange impact of 0.6%.


Duplicate of Nomad Foods: These Are The 4 Pivotal Factors Driving Its Performance In 2024 & 2025!

<ul>
<li>Nomad Foods, a prominent player in the frozen foods industry, experienced a mixed first quarter in 2024, balancing resilience in certain metrics with notable challenges typical of the consumer goods sector amidst a complex economic landscape.</li>
<li>The company reported a slight net sales increase of 1.1% and organic sales growth of 0.3%, aided by favorable foreign exchange rates.</li>
<li>Impressively, Nomad Foods has maintained positive organic sales growth for seven consecutive quarters.</li>
</ul>


Nomad Foods, a prominent player in the frozen foods industry, experienced a mixed first quarter in 2024, balancing resilience in certain metrics with notable challenges typical of the consumer goods sector amidst a complex economic landscape.
The company reported a slight net sales increase of 1.1% and organic sales growth of 0.3%, aided by favorable foreign exchange rates.
Impressively, Nomad Foods has maintained positive organic sales growth for seven consecutive quarters.


Nomad Foods: These Are The 4 Pivotal Factors Driving Its Performance In 2024 & 2025!

<ul>
<li>Nomad Foods reported another strong quarter of top results.</li>
<li>Fourth quarter organic sales rose by 1.9% - the sixth consecutive quarter to do so - while gross margins increased significantly both on a quarterly and annual basis.</li>
<li>The company also debuted a quarterly cash dividend, indicating the robust cash flows it continues to generate.</li>
</ul>


Nomad Foods reported another strong quarter of top results.
Fourth quarter organic sales rose by 1.9% - the sixth consecutive quarter to do so - while gross margins increased significantly both on a quarterly and annual basis.
The company also debuted a quarterly cash dividend, indicating the robust cash flows it continues to generate.


Nomad Foods: Initiation Of Coverage - An Integrated Growth Strategy & 3 Other Pivotal Growth Drivers

Technical Analyst, Vermilion Research

Joe Jasper

Technical Analyst

Technical and Quantitative Research

Vermilion Research

Vermilion’s objective is to deliver timely, actionable, and unique technical research to professional investors through the application of our various technical indicators.

Our research strategists seek to highlight securities which we believe are at major inflection points, based on our various technical and quantitative indicators, and offer asymmetric risk/return profiles. Our unique research methodology, centered on relative strength, enables our strategists to deliver superior investment recommendations.

Our process begins by organizing the universe of actively traded stocks into discrete sectors, then into industry groups. We then apply our technical and quantitative tools to identify developing price trends. Once attractive trends are identified within a selected sector or group, we screen for individual stocks which we believe offer the best risk/reward profile. We provide a historical perspective that often reveals, through our long-term charts, how price patterns often repeat themselves over time.

Technical Analysis

Health Care Select Sector SPDR / Technical Analysis

<ul>
<li>As the saying goes, "sector rotation is the lifeblood of a bull market." That appears to be exactly what is going on as we kick off 2024.</li>
<li>Leadership areas that have significantly outperformed since the October 2023 lows are starting to pull back rather hard -- and on above average volume (XLK, SMH, IGV, ARKK, IPO, BITQ)</li>
<li>Other Sectors are picking up the slack, namely Health Care (XLV), Staples (XLP), Utilities (XLU), Energy (XLE), Financials (XLF), and Real Estate (XLRE). Shift exposure toward value and defensives</li>
</ul>


As the saying goes, "sector rotation is the lifeblood of a bull market." That appears to be exactly what is going on as we kick off 2024.
Leadership areas that have significantly outperformed since the October 2023 lows are starting to pull back rather hard -- and on above average volume (XLK, SMH, IGV, ARKK, IPO, BITQ)
Other Sectors are picking up the slack, namely Health Care (XLV), Staples (XLP), Utilities (XLU), Energy (XLE), Financials (XLF), and Real Estate (XLRE). Shift exposure toward value and defensives


Upgrading Staples and Health Care to Market Weight; Shift to Value; Failed Breakouts for ARKK, IPO

United Kingdom

Nomad Foods Ltd. is a frozen foods company. The Company invests in food companies, supporting organic growth. Nomad Foods operates in various geographic regions and categories.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Nomad Foods (NOMD US)

Duplicate of Nomad Foods: These Are The 4 Pivotal Factors Driving Its Performance In 2024 & 2025!

Nomad Foods' second quarter 2024 earnings showcased a mix of strengths and cautious optimism amidst a slowly improving European market.

Baptista Research

Nomad Foods: These Are The 4 Pivotal Factors Driving Its Performance In 2024 & 2025!

The company reported a slight net sales increase of 1.1% and organic sales growth of 0.3%, aided by favorable foreign exchange rates.

Baptista Research

Nomad Foods: Initiation Of Coverage - An Integrated Growth Strategy & 3 Other Pivotal Growth Drivers

Nomad Foods reported another strong quarter of top results. Fourth quarter organic sales rose by 1.9% - the sixth consecutive quarter to do so -...

Baptista Research

Upgrading Staples and Health Care to Market Weight; Shift to Value; Failed Breakouts for ARKK, IPO

Shifting exposure toward value and defensives. Upgrading Consumer Staples $XLP and Health Care $XLV to market weight. $ARKK and $IPO with bearish...

Vermilion Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)